Compass Special Winter 2022

II Guide to Life Sciences Events

Euro B ioFa irs Compa ss

Pharmapack 2023

PACKAGING Pharmapack is Europe’s largest event dedicated to the pharmaceutical packaging and drug delivery industries. With an extensive conference agenda, it provides invaluable opportunities for networking and showcasing innovations.

Pharmapack 2023, taking place in hy brid format with in-person event on Feb 1st -2nd 2023, at the Paris Expo, Porte de Versailles Paris, France, is bringing together nearly 5500 pharma execu tives from 75 different countries and more than 350 exhibitors at the heart of the pharma packaging and drug deliv ery industry. The online platform (18th Jan -17th Feb, 2022) will be available to all registered participants.

Beyond the exhibition floor, 15 ses sions under Three Tracks- Device & Packaging Innovation, Large Volume

Come to Paris

GREETING The great thing about Pharmapack is that it remains the ab solute heart of the drug packaging and delivery industry, and the event retains a community- and in novation-driven at mosphere. The 2023

Drug Delivery & Combination Prod uct and Sustainability- delivered by industry experts will take place over the 2-day event to discuss the very lat est market trends in the drug delivery space. Running alongside will be work shops: Sustainable Materials, Autoin jectors, Labelling & Track & Trace or Contract Packaging and the returning ‘innovation gallery’ which will show case exhibitor innovations providing a window on the latest trends and cut ting-edge developments. The ‘learn ing labs’ will provide an opportunity to

hear from different exhibitors on their research and products.

The show floor will also feature Start-up hub, a platform for young start-up companies to exhibit their in novations, providing valuable brand visibility. All these sessions will be streamed for online audiences. In-per son attendees can also participate in guided expert-led walk-throughs on the ‘innovation tours’.

The much-awaited Pharmapack Awards will return this year celebrat ing the best products and innovations from the pharma packaging world un der two categories of ‘exhibitor inno vation’ and ‘health products’- with an awards ceremony on Feb 1st 2023. L

› QUICK FACTS

Pharmapack Europe will be online 18 th Jan - 17th Feb, and in person 1st – 2nd Feb, 2023 at the Paris Expo, Porte de Versailles, France.

In 2022, some 5000 attendees from 250 companies and 75 countries went to on the Paris Expo for what was one of the most convivial exhi bitions in memory.

edition will also feature a larger sus tainability agenda and the full return to onsite content – so already there is a real excitement amongst the indus try to return and a desire to accelerate their partnering.

Laura Murina Brand Manager, Pharmapack

› The latest content agenda for the 2023 event is available here – https://informamarkets. turtl.co/story/pharmapack2023-content-agenda/page/1.

› For more information and online registration, please visit https:// www.pharmapackeurope.com

18 th Jan 17 th Feb´23 -online In person 1st – 2nd Feb´23 at Paris Expo, Porte de Versailles, France

7th AMR Conference

16-17 March 2023 Congress Centre Basel Switzerland

The silent pandemic

AMR CONFERENCE 2023 The AMR Conference is the well established international platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss the latest updates in innovation and related policymaking needed to bring new antimicrobial treatments and diagnostics to the market.

Being the proven successful forum to connect relevant AMR stakeholders from industry, SMEs, finance, hospi tals, science, and policy, the seventh AMR Conference will provide two days packed with 20 sessions on the most urgent topics the AMR community is

›

QUICK FACTS

› Programme – 80+ high-level speakers in 20 sessions; pre-conference day & workshops

› Partnering – 1-to-1 partnering among the 400+ participants

› Innovation – Start-up competition, poster session and exhibition

Further information: www.amr-conference.com

currently discussing: How do policy makers take over their role in estab lishing most needed pull incentives? Which new initiatives have been start ed to push forward innovations in an timicrobial therapies and diagnostics? Which approaches take investigators to improve the efficiency of preclinical models as well as clinical trial designs?

Perspective of SMEs

The goal of the conference is to catchup with the latest trends in the de velopment of AMR products. The up coming conference will provide an important platform for all stakehold ers – in particular for small and me dium enterprises and start-up compa nies – to exchange views on innovation opportunities, development paths and alternative business models. The 2023 conference edition, hosted by the Euro

pean SME organisation BEAM Alliance in cooperation with bamconn GmbH, will again be the leading meeting of the AMR community in Europe. Together with other major stakeholders such as the Novo Repair Impact Fund and oth ers, the participants will explore fur ther strategies to improve conditions for companies developing novel anti microbials or AMR diagnostics. A spe cial focus of the event is targeted at the perspective of innovative SMEs, their R&D pipeline, requirements for regu lation and policy frameworks.

A 360°-view on AMR innovation

In addition, the conference will be a platform to discuss innovative strat egies to improve preclinical R&D as well as clinical trial designs. Among the partners of the event will be the EU-funded IMI AMR accelerator which is organizing its annual meeting as a pre-conference event on 15 March. Be yond the overview of antifungal and an tibacterial innovation landscape, the conference will also propose a special focus on how India is tackling the AMR issue. Among the further highlights will be a start-up competition, hosted by the pharma-backed incubator INCATE. Founders are requested to apply un til January 15, 2023. The top ten candi dates will qualify for a pitch during the conference.

Novel Antimicrobials & AMR Diagnostics

Novel Antimicrobials & AMR Diagnostics 7th AMR Conference

20–22 March 2023

Basel Switzerland

BIO-Europe® 2023

BIO-EUROPE SPRING It’s time once again to network and facilitate partnerships face-to-face at the premier springtime event for the life science industry.

The seventeenth annual BIO-Europe Spring premier springtime partnering conference is back in-person and will be taking place March 20–22, 2023 in Ba sel, Switzerland.

After being delivered digitally over the last two years, the event is expected to bring together over 2,800 leading exec utives from around the world to engage in more than 15,000 one-to-one meet ings. The event will cater to the needs of the entire value chain with world-class workshops and panels, innovative com pany presentations, active exhibition, and a variety of networking opportuni ties making this event an unrivalled fo rum for companies across the biotech value chain to meet and do business.

EBD Group is committed to pro viding a top-tier forum for the global

biopharma community to come togeth er. With that goal in mind, this year’s event will feature three days of digital partnering in the week following the inperson event.

partneringONE® will continue to allow delegates to experience the entire event from anywhere, including one-to-one meetings, on-demand content, and con ference activities. Scheduled meetings will take place face-to-face during the conference days as well as digitally dur ing the digital partnering days with links to a video conferencing solution.

We are thrilled to welcome you back to this “must-attend” springtime part nering event—making it a special re union for some and new beginnings for others.

Come to Basel

GREETING We are all thrilled to reu nite at the next BIOEurope Spring, to meet in-person and of course to make new connections. Ex panding on the success of EBD Group’s flagship conference, BIO-Europe® this last October, we anticipate this confer ence to exceed 2019 as well.

The last couple of years have fun damentally changed business devel opment and networking. While we are happy to have established new dig ital meeting solutions and virtual conferencing, the EBD team is thrilled to launch BIO-Europe Spring as a fusion of innovative digital solutions and a vibrant onsite event of unprece dented scope. We are looking forward to welcoming both attendees in Basel and online next spring.”

Shanks Portfolio Director –European Market, EBD Group

Chris

RECONNECTING AND FACILITATING GLOBAL PARTNERSHIPS

The seventeenth annual BIO-Europe Spring® is back in-person and will be taking place March 20–22, 2023 in Basel, Switzerland. This premier springtime partnering conference will bring together 2,800+ leading executives from around the world to engage in 15,000+ partnering meetings, world-class workshops and panels, innovative company presentations, active exhibition and as always, a variety of networking opportunities.

Register now and take advantage of early bird rates: bioeuropespring.com

Produced by:Supported by:

Swiss Biotech Day

SWISS BIOTECH DAY One of the most important biotech conferences in Europe, the Swiss Biotech Day, will once again attract over 1,000 senior life science experts from all over the world to Basel.

The Swiss Biotech Day in Basel is a fixed date in the biotechnology commu nity's calendar. In 2022, the conference demonstrated the impressive growth of the Swiss biotech industry and pre sented an exciting program with ideal networking opportunities across bor ders to over 1,200 participants from 36 nations.

in R&D, manufacturing, data manage ment, artificial intelligence and innova tive financing over one and a half days. Partnering allows to take advantage of opportunities and synergies arising from the close cooperation between biotech and pharma or to find interest ing partners for future projects, and to jointly drive the development of inno vative products and platform technol ogies. In addition, international biotech delegations use the "Global Village" to strengthen their ties with Switzer land as a biotech location and promote cross-border investments, public-pri vate partnerships, research and devel opment collaborations and exchange of talent.

An inspiring program with themati cally focused panel discussions, ex hibition, company presentations and partnering are the cornerstones of the lively networking event, accompanied by the trends and facts of the Swiss biotech industry and the celebration of the Swiss Biotech Success Stories Awards. L

Switzerland's most important biotech nology conference is equally attractive to biotech companies, their suppliers, investors and pharma corporations. In 2023, the Swiss Biotech Day will again offer high-level experts from the life science industry the space to network, discuss and discover trends

› Meet 1,000+ participants › 70+ exhibitors and global village with international delegations from all over the world › Swiss Biotech Success Stories Awards

Innovative biotech start-ups and medium-sized biotech companies › Thematically focused panel discussions

one-to-one partnering meetings

SWISS BIOTECH DAY

...ONE BIOTECH CLUSTER

As one of the leading biotechnology conferences, the Swiss Biotech Day has developed into a truly global networking day, attracting many international delegations.

What you can expect:

› Meet 1,000+ senior experts from the life science industry

› 70+ exhibitors and global village with international delegations from all over the world

› Swiss Biotech Success Stories Awards

› Innovative biotech start-ups and medium-sized biotech companies

“WHITE BIOTECHNOLOGY” WORKING GROUP

› Thematically focused panel discussions

› Swiss Biotech Report 2023

Leading chemical companies are exploring the opportunities that have been opened up by modern biotechnology, especially in the field of “white” or indusbiotechnology. And they are also applying these technologies, wherever it makes sense. The SBA takes initiatives seriously and has formed a working specifically dedicated to white biotechnology.

› Pre-scheduled one-to-one partnering meetings

› General Assembly of the Swiss Biotech Association

sector is internationally visible. The project-specific participating companies (most of them young and internationally less savvy) find a comprehensive partner which is helping to put them in the public window. The participating Life Science Regions are important internal carriers of the dynamics in the Biotech sector, thus enhancing the common understanding of the industry. This and more knowledge is brought into Europa Bio, the European Biotech Association, where the SBA is an active member.

SWISS BIOTECH...

...is an alliance of four leading Biotech regions of Switzerland (Bio Alps, BioPolo Ticino, Basel Area and Greater Zurich Area). They have combined efforts to streamline interests of the national biotech sector. The SWX Swiss Exchange holds a leading position in terms of lifescience listings and offers companies from that industry – be they located in Switzerland or abroad – access to an internationally recognised financial marketplace. The initiative was co-founded by the SBA which also manages the executive office of Swiss Biotech.

Media partners:

Swiss Industrial Biocatalysis Consortium is an important partner in this effort. The group includes leading multinational companies that support white biotechnology as a pillar of economic growth. The planned activities are in agreement with OECD strategies.

partnership with the Swiss Biotechnet (see pages the SBA develops training programmes and usesupport tools for the industry. It is of importance the industry specifies its training needs so that academic side can create tailor-made education. strategy ensures that the industry gets the right workforce with the right education. The SBA profits

Domenico Alexakis is Executive Director

Organized by:

For further information please visit

Connect in Pharma

FUTURE PHARMA After a successful launch in 2022, Connect in Pharma returns to Geneva to bring together the community of professionals shaping the future of drug delivery, manufacturing, outsourcing and packaging.

Connect in Pharma aims to drive inno vation, business and new partnerships in four key areas: innovative packaging, drug delivery systems, sub-contract ing, and manufacturing. Taking place in Geneva – the centre of a major phar maceutical and biopharma cluster –Connect in Pharma is the perfect place to meet key influencers from leading pharmaceutical groups, biopharma, in dustry clusters and suppliers.

After attending the 2022 event, Ele na Obrecht, Head of Maintenance at

Come to Geneva

GREETING Europe is home to a range of companies making extraordinary ad vances across drug delivery, manufac turingandpackaging,andwe’redelight ed to be able to bring that community to gether through Con nect in Pharma. Everyone who at tends Connect in Pharma can expect

Johnson & Johnson said: “I have been inspired by the newest trends in the market, including pharma and medi cal device innovations.”

With expert speakers, workshops, a gala dinner, receptions and loung es, Connect in Pharma offers unri valled opportunities to network, ne gotiate and foster connections with inspiring thought-leaders, world-wide key industry professionals and the most exciting innovators. Exhibitors and visitors can expect to connect with

to find something that inspires them, a new business lead or a solution to a technical challenge, and a host of new ideas to take back.

Lastyear’sfirst-everConnectinPhar ma event was a huge success. We can’t waittowelcomeourexhibitors,partners and visitors to an even more dynamic event in June 2023. We hope to see you in Geneva!

Renan Joel

14 & 15 June 2023

Palexpo, Geneva, Switzerland

www.connectinpharma.com

a curated collection of industry lead ing brands seeking to source packaging and production solutions in the phar maceutical industry.

In 2023, visitors will find even more content to support the industry’s navigation around the future of phar ma, with three stages tackling and advising on the trends and trials fac ing the pharma and biopharma com munity.

The theme of the event is creating and navigating the future of pharma.

The conference programme will ad dress key factors that will revolution ise the industry: sustainability, con nected health, AI and digitalisation, and human-centric approaches. Also, at the event, there will be speakers from Google, NASA, Forbes, GSK and Bayer who will speak about their ex periences and how the current use of technology will advance the pharma community. L

› QUICK FACTS

James Montero-MacColl

james.montero@easyfairs.com

+44 (0)20 3196 4428

https://www.connectinpharma.com/

REGISTRATION

https://www.connectinpharma.com/ visit/register-your-interest/ AGENDA

Divisional

Managing Director for Packaging at Easyfairs

https://www.connectinpharma.com/ visit/programme/